US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Ear Itch MD Anti-Itch Spray

Reason cGMP Deviations.

Eosera, Inc. NDC 72429-0071-5 D-1500-2020
Class II · Moderate risk Terminated

Nystatin Oral Suspension

Reason Subpotent drug: Out of specification for assay at the 15-month test interval.

PAI Holdings, LLC. dba Pharmaceutical Associates Inc NDC 0121-0810-16 D-1494-2020
Class II · Moderate risk Terminated

Leiper's Fork Distillery

Reason Labeling Not Elsewhere Classified: Product labeled to contain methanol.

Leiper's Fork Distillery D-1561-2020
Class III · Low risk Terminated

Extra Strength Headache Relief

Reason Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.

Ultra Seal Corporation D-1513-2020
Class III · Low risk Terminated

Pain Relief Maximum Strength

Reason Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.

Ultra Seal Corporation D-1512-2020
Class II · Moderate risk Terminated

Jaloma Antiseptic Hand Sanitizer

Reason cGMP deviations

Laboratorios Jaloma S.A. de C.V. NDC 65055-600-02 D-1555-2020
Class III · Low risk Terminated

Red Cross Oral Pain

Reason Labeling; Not Elsewhere Classified: The Mentholatum Company is initiating a voluntary recall due to an error in the labeling of the cotton pellet box found within the Red Cross Oral Pain blister pack. The cotton pellet box states that the product contains "Natural Eugenol Oil" in which it does not.

The Mentholatum Company NDC 10742-8902-1 D-1541-2020
Class II · Moderate risk Terminated

Hand Sanitizer

Reason Discoloration and Presence of Foreign Substance

Ecolab Inc NDC 47593-624-21 D-1539-2020
Class I · High risk Terminated

Heparin Sodium 10

Reason Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

SCA Pharmaceuticals D-1553-2020
Class I · High risk Terminated

Heparin Sodium 5

Reason Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

SCA Pharmaceuticals D-1552-2020
Class I · High risk Terminated

Heparin Sodium 5

Reason Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

SCA Pharmaceuticals D-1551-2020
Class I · High risk Terminated

Heparin Sodium 2

Reason Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

SCA Pharmaceuticals D-1550-2020
Class II · Moderate risk Terminated

Heparin Sodium 5

Reason Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.

SCA Pharmaceuticals NDC 70004-0650-46 D-1495-2020
Class I · High risk Terminated

Herbacil

Reason Chemical Contamination: HERBACIL, Antiseptic Hand Sanitizer, 70% Alcohol, was found to be below the label claim for ethanol content and contained methanol.

Broncolin, S.A. de C.V. D-1578-2020
Class II · Moderate risk Terminated

Herbacil

Reason CGMP Deviations: products were recalled because they were manufactured in the same facility as the product found to contain methanol.

Broncolin, S.A. de C.V. D-1577-2020
Class II · Moderate risk Terminated

Phentermine HCL Blue Speckled tablets

Reason CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Calvin Scott & Company, Inc. NDC 10702-0025-10 D-1532-2020
Class II · Moderate risk Terminated

Phentermine HCL White/Blue Speckled tablets

Reason CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Calvin Scott & Company, Inc. NDC 00527-1445-10 D-1531-2020
Class II · Moderate risk Terminated

Phentermine HCL White/Blue Speck Tabs 37.5 mg

Reason CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Calvin Scott & Company, Inc. NDC 53489-0676-10 D-1530-2020
Class II · Moderate risk Terminated

Phentermine HCL Blue/White Capsules

Reason CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Calvin Scott & Company, Inc. NDC 10702-0029-10 D-1529-2020
Class II · Moderate risk Terminated

Phentermine HCL Blue/Clear capsules

Reason CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Calvin Scott & Company, Inc. NDC 10702-0028-10 D-1528-2020